Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00933855
Other study ID # 08-148
Secondary ID
Status Completed
Phase N/A
First received July 1, 2009
Last updated November 22, 2011
Start date June 2009
Est. completion date June 2011

Study information

Verified date November 2011
Source Memorial Sloan Kettering Cancer Center
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

The purpose of this study is to test a class for Queens Cancer Center patients. We want to find out if patients think this program is helpful.


Description:

It is well accepted that effective physician-patient communication is associated with important outcomes. Communication training interventions for oncologists and other clinicians has been shown to be effective in changing behavior and improving outcomes. Less attention has been given to improving cancer patients' communication with their physicians. Most of the studies in this area have been focused on activating patients through training them to ask questions. Although question asking is a vitally important patient communication skill, other patient communication skills should also be encouraged for patients.

In the primary care setting, studies on patient communication training have focused on three additional communication skills to asking questions: presenting information, checking understanding, and expressing concerns. The goal of this study is to pilot test a patient communication workshop that builds on the work done in the primary care setting, offering an intervention that focuses on a broad range of skills. The proposal aims to improve communication skills in an underserved population, which may be a factor contributing to minority health disparities.


Recruitment information / eligibility

Status Completed
Enrollment 32
Est. completion date June 2011
Est. primary completion date June 2011
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients seeing a physician at Queens Cancer Center (not family members or partners)

- Able to provide informed consent.

Exclusion Criteria:

- Less than 18 years of age (as per self-report)

- Cognitive or physical impairment rendering patients incapable of providing informed consent to participate in the study.

- As the workshop will be given in English and the measures are all written in English, subjects who are not fluent in English will be excluded.

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Behavioral:
Questionnaires and training workshop
We will recruit a minimum of 1 and maximum of 12 patients for each workshop. The workshop will follow the approximate time table below: 10 minutes: Sign-in, welcome and introductions 25 minutes: Didactic session, videos and discussion 10 minutes: Group discussion 15 minutes: Closing plenary and final assessment

Locations

Country Name City State
United States Queens Hospital Center Jamaica New York

Sponsors (2)

Lead Sponsor Collaborator
Memorial Sloan Kettering Cancer Center Queens Health Network

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary To determine the feasibility of a patient communication training intervention. 2 years No
Secondary To attain preliminary data on the acceptability of the intervention through patient ratings of effectiveness and usefulness of the intervention. 2 years No
Secondary To attain preliminary data on the effect of a patient communication training intervention on patients' self-reported communication behaviors. 2 years No
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients